Aerosols for systemic delivery of macromolecules

Respiratory Care Clinics of North America

Volumn 7, Issue 2, 2001, Pages 261-275

  Newhouse, Michael T ^a,b,c   Corkery, Kevin J ^a  

^a NEKTAR THERAPEUTICS   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; CALCITONIN; DEOXYRIBONUCLEASE; DESMOPRESSIN ACETATE; DORNASE ALFA; FOLLITROPIN; GAMMA INTERFERON; GENTAMICIN; GONADORELIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH HORMONE; HEPARIN; INFLUENZA VACCINE; INSULIN; INTERLEUKIN 2; LOW MOLECULAR WEIGHT HEPARIN; LUNG SURFACTANT; MUCOLYTIC AGENT; PENTAMIDINE; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE; SOMATOSTATIN ANALOG; VASOPRESSIN DERIVATIVE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HUMAN TISSUE; MACROMOLECULE; METERED DOSE INHALER; MONITORING; NEBULIZER; NONHUMAN; PARTICLE SIZE; PRESCRIPTION;

EID: 0035165201     PISSN: 10785337     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5337(05)70033-2     Document Type: Article

References (22)

1. Regulatory issues concerning systemic delivery via the respiratory tract: Leuprolide as a demonstration model
2. Threshold limit values for chemical substances and physical agents and biological exposure indices 1992-1993
3. Bacterial contamination of home nebulizers
4. Diabetes and pharmacoeconomics
5. Contaminated medication nebulizers in mechanical ventilator circuits, source of bacterial aerosols
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
7. Aerosolized treatment of acute pulmonary infections
8. Intranasal delivery of peptides and proteins
9. Effect of inhaled natural interferon-α on diffuse bronchialveolar carcinoma
10. Aerosolized heparin
11. Improved airway targeting with the CFC-free HFA-beclomethasone metered dose inhaler compared with CFC-beclomethasone
12. Pulmonary absorption of therapeutic peptides and proteins
13. The effects of inhaled interferon γ innormal human airways
14. Aerosol α-1 antitrypsen treatment for cystic fibrosis
15. Economic evaluation of pharmacist involvement in disease management in a community setting
16. Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: Comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices
17. Issues in pulmonary delivery
18. Aerosol deposition in mechanically ventilated patients: Optimizing nebulizer delivery
19. Mechanisms of macromolecule absorption by the lungs
20. Inhaled insulin
21. Aerosol insulin-A brief review